Приказ основних података о документу

dc.creatorBurnett, James C.
dc.creatorOpsenica, Dejan M.
dc.creatorSriraghavan, Kamaraj
dc.creatorPanchal, Rekha G.
dc.creatorRuthel, Gordon
dc.creatorHermone, Ann R.
dc.creatorNguyen, Tam L.
dc.creatorKenny, Tara A.
dc.creatorLane, Douglas J.
dc.creatorMcGrath, Connor F.
dc.creatorSchmidt, James J.
dc.creatorVennerstrom, Jonathan L.
dc.creatorGussio, Rick
dc.creatorŠolaja, Bogdan A.
dc.creatorBavari, Sina
dc.date.accessioned2018-11-22T00:10:47Z
dc.date.available2018-11-22T00:10:47Z
dc.date.issued2007
dc.identifier.issn0022-2623
dc.identifier.urihttps://cherry.chem.bg.ac.rs/handle/123456789/828
dc.description.abstractWe previously identified structurally diverse small molecule (non-peptidic) inhibitors (SMNPIs) of the botulinum neurotoxin serotype A (BoNT/A) light chain (LC). Of these, several (including antimalarial drugs) contained a 4-amino-7-chloroquinoline (ACQ) substructure and a separate positive ionizable amine component. The same antimalarials have also been found to interfere with BoNT/A translocation into neurons, via pH elevation of the toxin-mediated endosome. Thus, this structural class of small molecules may serve as dual-function BoNT/A inhibitors. In this study, we used a refined pharmacophore for BoNT/A LC inhibition to identify four new, potent inhibitors of this structural class (IC(50)'s ranged from 3.2 to 17 mu M). Molecular docking indicated that the binding modes for the new SMNPIs are consistent with those of other inhibitors that we have identified, further supporting our structure-based pharmacophore. Finally, structural motifs of the new SMNPIs, as well as two structure-based derivatives, were examined for activity, providing valuable information about pharmacophore component contributions to inhibition.en
dc.publisherAmer Chemical Soc, Washington
dc.relationinfo:eu-repo/grantAgreement/MESTD/MPN2006-2010/142022/RS//
dc.rightsrestrictedAccess
dc.sourceJournal of Medicinal Chemistry
dc.titleA refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype a metalloproteaseen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractМцГратх, Цоннор Ф.; Опсеница, Дејан; Шолаја, Богдан A.; Лане, Доуглас Ј.; Сцхмидт, Јамес Ј.; Веннерстром, Јонатхан Л.; Гуссио, Рицк; Бавари, Сина; Срирагхаван, Камарај; Панцхал, Рекха Г.; Рутхел, Гордон; Кеннy, Тара A.; Нгуyен, Там Л.; Хермоне, Aнн Р.; Бурнетт, Јамес Ц.;
dc.citation.volume50
dc.citation.issue9
dc.citation.spage2127
dc.citation.epage2136
dc.identifier.wos000245954600015
dc.identifier.doi10.1021/jm061446e
dc.citation.other50(9): 2127-2136
dc.citation.rankaM21
dc.identifier.pmid17417831
dc.type.versionpublishedVersionen
dc.identifier.scopus2-s2.0-34247633446


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу